EP300 promotes bladder cancer cell migration through SNAI2
PLOS One · 08.06.2026 · 21 (6) · e0347209
DOI: 10.1371/journal.pone.0347209 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.06.2026. Verfasst von Qing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Cell Metabolism and Disease, Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cell Movement, Snail Family Transcription Factors, E1A-Associated p300 Protein. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Hybribio Biotech Funding.
Abstract (Originalsprache)
EP300, a frequently mutated transcriptional coactivator in bladder cancer, has been demonstrated to positively correlate with malignancy in various cancers. Highly aggressive bladder cancers are often associated with muscle-invasive progression, a process closely linked to the epithelial-mesenchymal transition (EMT) capability of bladder cancer. Here, we performed immunohistochemical staining on bladder cancer tissues and adjacent normal tissues obtained from radical cystectomy to validate the positive association between EP300 and bladder cancer malignancy. We observed that A485, a small-molecule inhibitor of EP300, significantly inhibited cell migration in multiple bladder cancer cell lines (SW780, T24, RT4 and 5637) both in scratch wound healing and Transwell assays. Additionally, take the advantage of organoid-3D culture system, A485 disrupted the formation of inter-organoids connecting tubular structures in T24 cell line, while A485 also disrupted the organoid migration from matrix out-toward the non-matrix region both in SW780 and 5637 cell lines. In in vivo experiment, A485 showed a trend toward inhibiting BBN-induced bladder cancer invasion in mice. Bulk RNAseq analysis revealed that A485 commonly downregulated SNAI2-related signaling pathways across multiple bladder cancer cell lines. Furthermore, western blotting confirmed that A485 significantly reduced the global level of acetylation of histone H3 at lysine 27 (H3K27ac) as well as SNAI2 expression in T24 and SW780 cell lines. Indeed, overexpression of SNAI2 enhanced the migratory capacity of bladder cancer cells via Transwell assay. Collectively, our findings demonstrate that EP300 promoted bladder cancer cell migration via up-regulating SNAI2, targeting EP300 could be a potential therapeutic strategy to inhibit the process of bladder cancer invasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Cell Metabolism and Disease, Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China.
- Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
ORCID-Profile: Chunming Guo
Förderung
- National Natural Science Foundation of China
- Guangdong Hybribio Biotech Funding
Zitieren
APA
Zhang, Q., He, C., Hong, Y., Huang, T., Deng, S., Peng, C., Wang, H., & Guo, C. (2026). EP300 promotes bladder cancer cell migration through SNAI2. PLOS One, 21(6), e0347209. https://doi.org/10.1371/journal.pone.0347209
Vancouver
Zhang Q, He C, Hong Y, Huang T, Deng S, Peng C, et al. EP300 promotes bladder cancer cell migration through SNAI2. PLOS One. 2026;21(6):e0347209. doi:10.1371/journal.pone.0347209
BibTeX
@article{Zhang2026,
author = {Zhang, Qing and He, Chongjie and Hong, Yingzhou and Huang, Tao and Deng, Shuangsheng and Peng, Cheng and Wang, Haifeng and Guo, Chunming},
title = {EP300 promotes bladder cancer cell migration through SNAI2},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0347209},
doi = {10.1371/journal.pone.0347209}
}
EUVIMED